as on December 6, 2025 at 2:29 am IST
Day's Low
5.50%
Downside
52 Week's Low
52 Week's High
7.34%
Downside
45.87%
Upside
Check An2 Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$29.2M
EPS (TTM)
-1.12
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-45.91%
Compare market cap, revenue, PE, and other key metrics of An2 Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $29.2M | NA | NA | 0.00% | |
| BUY | $43.5B | 408.22% | -16.34 | -264.83% | |
| BUY | $61.5B | 253.6% | 1661.93 | 1.36% | |
| BUY | $117.3B | 99.49% | 32.16 | 31.35% | |
| BUY | $76.6B | 45.87% | 17.31 | 32.13% |
The An2 Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
An2 Therapeutics, Inc. investment value today
Current value as on today
₹81,633
Returns
Returns from An2 Therapeutics, Inc. Stock
Dollar Returns*
₹5,939 (+5.94%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for An2 Therapeutics, Inc.. Average target price of $1
Get share price movements and forecasts by analysts on An2 Therapeutics, Inc..
What analysts predicted
-9%DOWNSIDE
Target Price
$1
Current Price
$1.09
Analyzed by
11 Analysts
Target
$1.00
An2 Therapeutics, Inc. target price $1, a slight downside of -9% compared to current price of $1.09. According to 11 analysts rating.
Search interest for An2 Therapeutics, Inc. Stock has increased by 90% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:90% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 194.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 995.0% return, outperforming this stock by 1083.0%
Price Dip
![]()
In the last 3 years, ANTX stock has moved down by -88.0%
| Organisation | An2 Therapeutics, Inc. |
| Headquarters | 1800 El Camino Real, Menlo Park, CA, United States, 94027 |
| Industry | Services |
| CEO | Mr. Eric E. Easom |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Vince Hernandez | Senior VP of Research & Head of Chemistry |
Mr. Eric E. Easom | Co-Founder, CEO, President & Chairman of the Board |
Mr. Joseph S. Zakrzewski | Co-Founder & Independent Chairman of the Board |
Mr. Joshua M. Eizen J.D. | Chief Legal Officer, COO & Corporate Secretary |
Dr. Stephen David Prior Ph.D. | Chief Strategy Officer |
Ms. Lucy O. Day CPA | CFO, Principal Financial Officer & Principal Accounting Officer |
Dr. George Harrison Talbot FACP, M.D. | Co-Founder & Senior Clinical Advisor |
Dr. Michael R. K. Alley Ph.D. | Co-Founder, Senior VP of Research Fellow & Head of Biology |
Dr. Sanjay Chanda Ph.D. | Chief Development Officer |
An2 Therapeutics, Inc. share price today is $1.09 as on at the close of the market. An2 Therapeutics, Inc. share today touched a day high of $1.09 and a low of $1.03.
An2 Therapeutics, Inc. share touched a 52 week high of $1.59 on and a 52 week low of $1.01 on . An2 Therapeutics, Inc. stock price today i.e. is closed at $1.09,which is 31.45% down from its 52 week high and 7.92% up from its 52 week low.
An2 Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in An2 Therapeutics, Inc. (ANTX) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in An2 Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on An2 Therapeutics, Inc. share’s latest price of $1.09 as on December 6, 2025 at 2:29 am IST, you will get 9.1743 shares of An2 Therapeutics, Inc.. Learn more about
fractional shares .